Home / Cefuroxime / Canada
CA ATC J01DC02 · updated 2 Nov 2026
Cefuroxime shortage in Canada
Is there a Cefuroxime shortage in Canada?
Yes. As of 2 Nov 2026, 4 Cefuroxime products are reported short in Canada, the first since 31 Mar 2020. No return date has been given. Main reason: other.
Also short in Germany, Spain, Ireland, Czechia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | CEFUROXIME FOR INJECTION, USP (25 VIALS) | STERIMAX INC | 31 Mar 2020 | not given | Other Other (Please describe in comments) |
| CA | CEFUROXIME FOR INJECTION, USP (10 VIALS) | STERIMAX INC | 31 Jul 2020 | not given | Other Other (Please describe in comments) |
| CA | CEFUROXIME FOR INJECTION, USP (25 VIALS) | STERIMAX INC | 30 Oct 2020 | not given | Other Other (Please describe in comments) |
| CA | APO-CEFUROXIME (60 BTL) | APOTEX INC | 4 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.